236 Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation : A Retrospective Cohort Study
暂无分享,去创建一个
N. Kneteman | P. Marotta | M. Senzolo | B. Al-judaibi | F. S. Cardoso | C. Karvellas | Lukasz Kwapisz | M. Wells | M. Alghanem | Fayaz Handou | L. Kwapisz
[1] S. Agarwal,et al. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients , 2016, Transplantation.
[2] G. Ioannou,et al. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[3] T. Hibi,et al. When and Why Portal Vein Thrombosis Matters in Liver Transplantation: A Critical Audit of 174 Cases , 2014, Annals of surgery.
[4] R. Porte,et al. Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[5] R. Moreau,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.
[6] R. Porte,et al. Management of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Transplantation: A Systematic Review , 2012, Transplantation.
[7] E. Tsochatzis,et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[8] B. Caffo,et al. MELD Exceptions and Rates of Waiting List Outcomes , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] A. Cucchetti,et al. Portal Vein Thrombosis and Liver Transplantation: Evolution During 10 Years of Experience at the University of Bologna , 2011, Annals of surgery.
[10] R. Merion,et al. Portal vein thrombosis and liver transplant survival benefit , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] J. Marrero,et al. Portal vein thrombosis and survival in patients with cirrhosis , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] World Medical Association (WMA),et al. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.
[13] A. Gasbarrini,et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. , 2009, Journal of hepatology.
[14] M. Senzolo,et al. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? , 2009, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[15] L. Romano,et al. Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis , 2009, Journal of clinical gastroenterology.
[16] Douglas G Altman,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, BMJ.
[17] J. Bragg-Gresham,et al. Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] V. Paradis,et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation , 2005, Gut.
[19] C. Yurdaydın,et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis , 2005, European journal of gastroenterology & hepatology.
[20] M. Margaglione,et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. , 2004, Journal of hepatology.
[21] O. Boillot,et al. Eversion Thrombectomy for Portal Vein Thrombosis During Liver Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[22] M. Margaglione,et al. Portal Vein Thrombosis after Variceal Endoscopic Sclerotherapy in Cirrhotic Patients: Role of Genetic Thrombophilia , 2002, Endoscopy.
[23] G. Klintmalm,et al. Thrombendvenectomy for Organized Portal Vein Thrombosis at the Time of Liver Transplantation , 2002, Annals of surgery.
[24] Portal Vein Thrombosis in Adults Undergoing Liver Transplantation: Risk Factors, Screening, Management, and Outcome , 2000 .
[25] M. Margaglione,et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis , 2000, Hepatology.
[26] T. Starzl,et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. , 1996, The Journal of surgical research.
[27] E. Schiff,et al. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study. , 2015, Gastroenterology.
[28] M. Manns,et al. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation. , 2015, Gastroenterology.
[29] B. Raval,et al. Portal vein thrombosis: imaging findings. , 1994, AJR. American journal of roentgenology.